Virax Biolabs VRAX Income Statement (2022-2026)

NASDAQ VRAX
$1.41 +0.01 (+1.09%)
As of: Oct 20, 2026 · 1:57 PM EDT
Reported Financials

Virax Biolabs Quarterly Income Statement

Periods 9 quarters
Latest Mar 2026

Virax Biolabs income statement data for the quarter ended Mar 2026. This income statement covers 9 quarters of results from Mar 2022 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Mar2022 Sep2022 Mar2023 Sep2023 Mar2024 Sep2024 Mar2025 Sep2025 Mar2026
Additional items
Shares Outstanding 0.01M0.01M0.04M0.04M0.08M0.08M0.15M0.15M0.40M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 0.01M0.01M0.04M0.04M0.08M0.08M0.15M0.15M0.40M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 0.01M0.06M0.10M0.17M0.58M

Virax Biolabs Income Statement API

Pull Virax Biolabs's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VRAX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY